Drug Information

Drug General Information
Drug ID
D07GNO
Former ID
DNCL002072
Drug Name
KRN-330
Drug Type
Antibody
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 1/2 [532728]
Company
Kyowa Hakko Kirin Pharma
Target and Pathway
Target(s) Cell surface A33 antigen Target Info [532728]
References
Ref 532728Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer. Invest New Drugs. 2014 Aug;32(4):682-90.
Ref 532728Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer. Invest New Drugs. 2014 Aug;32(4):682-90.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.